European Journal of Medicinal Chemistry p. 187 - 199 (2017)
Update date:2022-08-02
Topics: Synthesis Trypanosoma cruzi Activity 2D-QSAR Neolignan-based Diaryl-tetrahydrofuran and -furan analogues Trypanothione reductase Assessment
Hartmann, Ana Paula
de Carvalho, Marcelo Rodrigues
Bernardes, Lilian Sibelle Campos
de Moraes, Milena Hoehr
de Melo, Eduardo Borges
Lopes, Carla Duque
Steindel, Mario
da Silva, Jo?o Santana
Carvalho, Ivone
Two series of diaryl-tetrahydrofuran and -furan were synthesised and screened for anti-trypanosomal activity against trypomastigote and amastigote forms of Trypanosoma cruzi, the causative agent of Chagas disease. Based on evidence that modification of a natural product may result in a more effective drug than the natural product itself, and using known neolignan inhibitors veraguensin 1 and grandisin 2 as templates to synthesise simpler analogues, remarkable anti-trypanosomal activity and selectivity were found for 3,5-dimethoxylated diaryl-furan 5c and 2,4-dimethoxylated diaryl-tetrahydrofuran 4e analogues with EC50 0.01 μM and EC50 0.75 μM, respectively, the former being 260-fold more potent than veraguensin 1 and 150-fold better than benznidazole, the current available drugs for Chagas disease treatment. The ability of the most potent anti-trypanosomal compounds to penetrate LLC-MK2 cells infected with T. cruzi amastigotes parasite was tested, which revealed 4e and 5e analogues as the most effective, causing no damage to mammalian cells. In particular, the majority of the derivatives were non-toxic against mice spleen cells. 2D-QSAR studies show the rigid central core and the position of dimethoxy-aryl substituents dramatically affect the anti-trypanosomal activity. The mode of action of the most active anti-trypanosomal derivatives was investigated by exploring the anti-oxidant functions of Trypanothione reductase (TR). As a result, diarylfuran series displayed the strongest inhibition, highlighting compounds 5d-e (IC50 19.2 and 17.7 μM) and 5f-g (IC50 8.9 and 7.4 μM), respectively, with similar or 2-fold higher than the reference inhibitor clomipramine (IC50 15.2 μM).
View MoreTaizhou Sunny Chemical Co.,Ltd
Contact:+86-523-86920899 +86-13951172783
Address:No.11 Xingyuang road, Gaoyong Chemical Industry Park, Gaogang Jiangsu China
RongCheng Tianyu Technology Co.,Ltd.
Contact:86-631-7519595
Address:220Ping Donghai Road RongChengCity,ShangDong Province China
Yingkou Sanzheng Organic Chemical Co. Ltd.
Contact:+86-417-3638818
Address:25 Gengxinli Village, Daqing Road, Yingkou, Liaoning, China
Jinhua Haoyuan Chemical CO., LTD
Contact:86-579-82465583
Address:Jinhua,Zhejiang
Zhejiang Sucon Silicone Co.,Ltd
Contact:+86-575-88046692
Address:Qisheng Rd., Paojiang Industrial Zone, Shaoxing, Zhejiang, China.
Doi:10.1039/c3ra42493f
(2013)Doi:10.1021/ja00184a036
(1989)Doi:10.1016/j.bmc.2018.02.008
(2018)Doi:10.1016/S0020-1693(00)90603-0
(1988)Doi:10.1016/j.poly.2008.12.004
(2009)Doi:10.1016/0013-4686(68)85025-X
(1968)